ArticleCancer gene therapy2025
Chimeric Ad5/35 oncolytic adenovirus overcome preexisting neutralizing antibodies and enhance tumor targeting efficiency.
Zhoutong Dai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it